Mutations in POLE and survival of colorectal cancer patients - link to disease stage and treatment

Cancer Medicine

Volumn 3, Issue 6, 2014, Pages 1527-1538

  Stenzinger, Albrecht ^a   Pfarr, Nicole ^a   Endris, Volker ^a   Penzel, Roland ^a   Jansen, Lina ^b   Wolf, Thomas ^a,c   Herpel, Esther ^a   Warth, Arne ^a   Klauschen, Frederick ^d   Kloor, Matthias ^e   Roth, Wilfried ^a   Bläker, Hendrik ^d   Chang Claude, Jenny ^b   Brenner, Hermann ^b,c   Hoffmeister, Michael ^b   Weichert, Wilko ^a,b,c  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c German Consortium for Translational Cancer Research DKTK   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Colorectal cancer; DACHS; MSS; Mutation; POLE; Polymerase lunate ; Ultramutator phenotype

Indexed keywords

DNA DIRECTED DNA POLYMERASE ALPHA; MICROSATELLITE DNA; POLE PROTEIN, HUMAN;

AGED; CANCER STAGING; CASE CONTROL STUDY; COHORT ANALYSIS; COLORECTAL NEOPLASMS; EPIDEMIOLOGY; FEMALE; GENETICS; GERMANY; HUMAN; MALE; METABOLISM; MORTALITY; MUTATION; PATHOLOGY; PROGNOSIS; SURVIVAL ANALYSIS;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; COLORECTAL NEOPLASMS; DNA POLYMERASE II; FEMALE; GERMANY; HUMANS; MALE; MICROSATELLITE REPEATS; MUTATION; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84990888130     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.305     Document Type: Article

References (30)

1. Ferlay, J., H. R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127:2893-2917.
2. Markowitz, S. D., D. M. Dawson, J. Willis, and J. K. Willson. 2002. Focus on colon cancer. Cancer Cell 1:233-236.
3. Lengauer, C., K. W. Kinzler, and B. Vogelstein. 1997. Genetic instability in colorectal cancers. Nature 386:623-627.
4. Fearon, E. R. 2011. Molecular genetics of colorectal cancer. Annu. Rev. Pathol. 6:479-507.
5. Cunningham, D., W. Atkin, H. J. Lenz, H. T. Lynch, B. Minsky, B. Nordlinger, et al. 2010. Colorectal cancer. Lancet 375:1030-1047.
6. Issa, J. P. 2004. CpG island methylator phenotype in cancer. Nat. Rev. Cancer 4:988-993.
7. Weisenberger, D. J., K. D. Siegmund, M. Campan, J. Young, T. I. Long, M. A. Faasse, et al. 2006. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat. Genet. 38:787-793.
8. Palles, C., J. B. Cazier, K. M. Howarth, J. B. Cazier, K. M. Howarth, E. Domingo, et al. 2013. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat. Genet. 45:136-144.
9. The Cancer Genome Atlas Network. 2012. Comprehensive molecular characterization of human colon and rectal cancer. Nature 18:330-337.
10. Seshagiri, S., E. W. Stawiski, S. Durinck, Z. Modrusan, E. E. Storm, C. B. Conboy, et al. 2012. Recurrent R-spondin fusions in colon cancer. Nature 488:660-664.
11. Yoshida, R., K. Miyashita, M. Inoue, A. Shimamoto, Z. Yan, A. Egashira, et al. 2011. Concurrent genetic alterations in DNA polymerase proofreading and mismatch repair in human colorectal cancer. Eur. J. Hum. Genet. 19:320-325.
12. Pursell, Z. F., I. Isoz, E. B. Lundström, E. Johansson, and T. A. Kunkel. 2007. Yeast DNA polymerase epsilon participates in leading-strand DNA replication. Science 317:127-130.
13. Morrison, A., A. L. Johnson, L. H. Johnston, and A. Sugino. 1993. Pathway correcting DNA replication errors in Saccharomyces cerevisiae. EMBO J. 12:1467-1473.
14. Morrison, A., J. B. Bell, T. A. Kunkel, and A. Sugino. 1991. Eukaryotic DNA polymerase amino acid sequence required for 3′-5′ exonuclease activity. Proc. Natl. Acad. Sci. USA 88:9473-9477.
15. Burgers, P. M. 2009. Polymerase dynamics at the eukaryotic DNA replication fork. J. Biol. Chem. 284:4041-4045.
16. Albertson, T. M., M. Ogawa, J. M. Bugni, L. E. Hays, Y. Chen, Y. Wang, et al. 2009. DNA polymerase epsilon and delta proofreading suppress discrete mutator and cancer phenotypes in mice. Proc. Natl. Acad. Sci. USA 106:17101-17104.
17. Brenner, H., J. Chang-Claude, C. M. Seiler, A. Rickert, and M. Hoffmeister. 2011. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann. Intern. Med. 154:22-30.
18. Hoffmeister, M., H. Bläker, M. Kloor, W. Roth, C. Toth, E. Herpel, et al. 2013. Body mass index and microsatellite instability in colorectal cancer: a population-based study. Cancer Epidemiol. Biomarkers Prev. 22:2303-2311.
19. Rudolph, A., C. Toth, M. Hoffmeister, W. Roth, E. Herpel, P. Schirmacher, et al. 2012. Expression of estrogen receptor beta and prognosis of colorectal cancer. Br. J. Cancer 107:831-839.
20. Bickeböller, M., K. E. Tagscherer, M. Kloor, L. Jansen, J. Chang-Claude, H. Brenner, et al. 2014. Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival. Oncogene doi: 10.1038/onc.2014.40. [Epub ahead of print]
21. Choi, Y., G. E. Sims, S. Murphy, J. R. Miller, and A. P. Chan. 2012. Predicting the functional effect of amino acid substitutions and Indels. PLoS ONE 7:e46688.
22. Kumar, P., S. Henikoff, and P. C. Ng. 2009. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4:1073-1081.
23. Schwarz, J. M., C. Rödelsperger, M. Schuelke, and D. Seelow. 2010. MutationTaster evaluates disease-causing potential of sequence alterations. Nat. Methods 7:575-576.
24. Ramensky, V., P. Bork, and S. Sunyaev. 2002. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 30:3894-3900.
25. Zhang, X., F. R. Loberiza, J. P. Klein, and M. J. Zhang. 2007. A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model. Comput. Methods Programs Biomed. 88:95-101.
26. Brenner, H., M. Kloor, and C. P. Pox. 2013. Colorectal cancer. Lancet pii: S0140-6736(13)61649-9. [Epub ahead of print]
27. Seshagiri, S. 2013. The burden of faulty proofreading in colon cancer. Nat. Genet. 45:1261.
28. Church, D. N., S. E. Briggs, C. Palles, E. Domingo, S. J. Kearsey, J. M. Grimes, et al. 2013. DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer. Hum. Mol. Genet. 22:2820-2828.
29. Cancer Genome Atlas Research Network, C. Kandoth, N., Schultz, A. D. Cherniack, R. Akbani, Y. Liu, et al. 2013. Integrated genomic characterization of endometrial carcinoma. Nature 497:67-73.
30. Jackson, S. P., and J. Bartek. 2009. The DNA-damage response in human biology and disease. Nature 461:1071-1078.